ReviewWorld journal of surgical oncology2026
The crisis of manufactured scholarship: confronting AI-driven "letter-bombing" and profile inflation in medical journals.
Review in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-publication peer review faces a emerging systemic vulnerability from 'letter-bombing'-the proliferation of high-volume, potentially machine-generated critiques that exploit citable correspondence units, creating a plausible risk of academic metric inflation. Driven by the democratization of Large Language Models (LLMs), these automated submissions frequently exploit formatting loopholes to manipulate public indicators like the h-index. The problem is particularly observable in data-intensive specialties like surgical oncology, where abstract-level statistical critiques targeting complex clinical trials risk muddying translational research communication. Drawing on documented bibliometric anomalies and confirmed editorial actions, this piece discusses operational definitions of abnormal correspondence volumes and proposes a multi-layered framework. To protect the scientific record, we propose an enforceable framework for editorial boards: implementing strict metadata labeling to close indexing loopholes, verifying author history, and mandating the "Right of Simultaneous Reply" as a universal baseline publishing standard.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.